NeuPath Health Inc experienced minor fluctuations this week amid notable company news.
NeuPath Health Inc (NPTH.V) closed at C$0.54 on Friday, reflecting a stable performance with no change from the previous day. Over the past week, the stock has seen a decrease of 1.82%, continuing a broader trend that has seen it decline by 11.48% in the last month. Despite the recent downturn, the company has reported strong financial results, which may warrant further attention from investors.
Investor takeaway: Investors should note NeuPath's recent financial performance and leadership transition, which may influence future stock performance. While the stock has seen recent declines, the company's growth trajectory and revenue projections may present opportunities for long-term investors.
Advertisement
NeuPath Health Inc
NPTH.V
NPTH.V
NeuPath Health Inc
WealthAwesomeMarket cap
$30.77M
P/E
27.0x
52W high
$0.68
52W low
$0.28
1W change
-1.82%
Beta
1.04
Analyst Price Targets
Based on analyst covering NPTH
Wall Street analysts forecast NPTH stock price to rise 41.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.77
+41.7% Upside
Current Price
C$0.54
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NPTH's historical volatility
30-Day Vol
36.2%
Annualized
90-Day Vol
49.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.45
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.51 | C$0.45 โ C$0.58 |
| 60 trading days | C$0.48 | C$0.40 โ C$0.57 |
| 90 trading days | C$0.45 | C$0.36 โ C$0.56 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
NeuPath Health Reports Record Revenue of C$21.5 Million in Q1 2026
The company's first-quarter revenue marks an 11% year-over-year increase, reflecting solid growth despite current stock performance.
Bull case
The announcement of record revenues and positive cash flows, along with a projected increase in revenue for 2025, points to a positive growth outlook for NeuPath Health. The company's ability to generate significant revenue in a competitive healthcare market is a promising sign.
Bear case
Even with positive financial results, the stock has shown a downward trend recently, with trading volumes significantly below average. This could indicate cautious sentiment among investors, especially with upcoming leadership changes.
Recent Price Action
Advertisement
NeuPath Health Inc's stock closed at C$0.54, remaining unchanged from the previous day. Over the past week, the stock has decreased by 1.82%, reflecting a broader trend of decline, with the stock down 11.48% over the last month. Year-to-date, NPTH.V shows a modest gain of 3.85%.
Company News
NeuPath Health recently announced its first-quarter 2026 results, reporting total revenue of C$21.5 million, an 11% increase year-over-year. This growth was complemented by positive cash flows and an Adjusted EBITDA of C$1.5 million, a 15% rise from the previous year. Additionally, the company is undergoing a leadership transition, with Stephen Lemieux set to become CEO effective April 1, 2026, which may influence future company direction and performance.
Technical Picture
From a technical standpoint, NeuPath Health's stock is currently trading below its 50-day moving average of C$0.60, indicating a potential bearish trend in the short term. The stock is at the lower end of its 52-week range of C$0.28 to C$0.68, currently sitting at 65% of this range. The 200-day moving average is at C$0.54, suggesting the stock is performing in line with its long-term trend. The beta of 1.04 indicates that the stock's volatility is slightly above the market average.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
